Bisphosphonates and osteonecrosis: potential treatment or serious complication?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19358907.
- Also identified by DOI 10.1016/j.ocl.2008.12.002.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
They are commonly used to treat osteoporosis and other diseases that involve osteoclast-mediated bone resorption, including Paget's disease and multiple myeloma. Their use in treating osteonecrosis of the femoral head has been studied and theoretically holds promise. There are complications associated with these medications, however, including the development of osteonecrosis in the jaw.
Medical subject headings
- Bone Density Conservation Agents
- Diphosphonates
- Osteonecrosis